Clinical Trial Update: Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zinc sulfate to prevent loss of taste in patients receiving radiation therapy for head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysgeusia
• Head and Neck Cancer

Drugs mentioned

• Zinc sulfate (Zinc sulfate)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Dysgeusia, Head and Neck Cancer | Phase 3 | Status: COMPLETED